| Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets S Khan, S Shukla, S Sinha, SM Meeran Cytokine & growth factor reviews 24 (6), 503-513, 2013 | 169 | 2013 |
| Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention S Shukla, SM Meeran, SK Katiyar Cancer letters 355 (1), 9-17, 2014 | 132 | 2014 |
| Epigenetics of cancer stem cells: Pathways and therapeutics S Shukla, SM Meeran Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (12), 3494-3502, 2014 | 130 | 2014 |
| Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications SM Meeran, SN Patel, Y Li, S Shukla, TO Tollefsbol PloS one 7 (5), e37748, 2012 | 119 | 2012 |
| Synthesis of β-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells SU Dighe, S Khan, I Soni, P Jain, S Shukla, R Yadav, P Sen, SM Meeran, ... Journal of Medicinal Chemistry 58 (8), 3485-3499, 2015 | 98 | 2015 |
| Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis S Shukla, S Sinha, S Khan, S Kumar, K Singh, K Mitra, R Maurya, ... Scientific reports 6 (1), 1-17, 2016 | 66 | 2016 |
| Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis S Sinha, S Khan, S Shukla, AD Lakra, S Kumar, G Das, R Maurya, ... The international journal of biochemistry & cell biology 77, 41-56, 2016 | 58 | 2016 |
| Improved tumor control through t-cell infiltration modulated by ultra-high dose rate proton FLASH using a clinical pencil beam scanning proton system N Rama, T Saha, S Shukla, C Goda, D Milewski, AE Mascia, RE Vatner, ... International Journal of Radiation Oncology, Biology, Physics 105 (1), S164-S165, 2019 | 56 | 2019 |
| Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis S Shukla, S Khan, S Kumar, S Sinha, M Farhan, HK Bora, R Maurya, ... Cancer prevention research 8 (6), 552-562, 2015 | 52 | 2015 |
| Centchroman suppresses breast cancer metastasis by reversing epithelial–mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling S Khan, S Shukla, S Sinha, AD Lakra, HK Bora, SM Meeran The International Journal of Biochemistry & Cell Biology 58, 1-16, 2015 | 51 | 2015 |
| Epigenetics of breast cancer: Clinical status of epi-drugs and phytochemicals S Shukla, D Penta, P Mondal, SM Meeran Breast cancer metastasis and drug resistance: challenges and progress, 293-310, 2019 | 48 | 2019 |
| Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells S Sinha, S Shukla, S Khan, TO Tollefsbol, SM Meeran Molecular and cellular endocrinology 406, 102-114, 2015 | 42 | 2015 |
| The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-CateninSmall-Molecule Inhibitor of FOXM1 Inhibits Carcinogenesis S Shukla, D Milewski, A Pradhan, N Rama, K Rice, T Le, MJ Flick, S Vaz, ... Molecular cancer therapeutics 18 (7), 1217-1229, 2019 | 31 | 2019 |
| Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach S Krishna, S Shukla, AD Lakra, SM Meeran, MI Siddiqi Journal of Molecular Graphics and Modelling 75, 174-188, 2017 | 29 | 2017 |
| FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation M Black, P Arumugam, S Shukla, A Pradhan, V Ustiyan, D Milewski, ... Molecular Biology of the Cell 31 (13), 1411-1424, 2020 | 23 | 2020 |
| Epigenetic targets in cancer and aging: dietary and therapeutic interventions S Khan, S Shukla, S Sinha, SM Meeran Expert opinion on therapeutic targets 20 (6), 689-703, 2016 | 23 | 2016 |
| Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis S Khan, S Shukla, M Farhan, S Sinha, AD Lakra, D Penta, A Kannan, ... Life Sciences 256, 117976, 2020 | 19 | 2020 |
| Telomeric repeat containing RNA (TERRA): aging and cancer S Sinha, S Shukla, S Khan, M Farhan, MA Kamal, S Musthapa Meeran CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015 | 18 | 2015 |
| Genetics and epigenetics of lung cancer: mechanisms and future perspectives S Shukla, S Khan, T O Tollefsbol, S M Meeran Current Cancer Therapy Reviews 9 (2), 97-110, 2013 | 15 | 2013 |
| FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma D Milewski, S Shukla, BE Gryder, A Pradhan, J Donovan, P Sudha, ... Oncogene 40 (12), 2182-2199, 2021 | 14 | 2021 |
Syed Musthapa MeeranSenior Principal Scientist & Professor, Department of Biochemistry, CSIR-CFTRIVerified email at cftri.res.in
